載入...
PD-L1, Galectin-9 and CD8(+) tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma
Novel systemic treatments for hepatocellular carcinoma (HCC) are strongly needed. Immunotherapy is a promising strategy that can induce specific antitumor immune responses. Understanding the mechanisms of immune resistance by HCC is crucial for development of suitable immunotherapeutics. We used imm...
Na minha lista:
| 發表在: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5353918/ https://ncbi.nlm.nih.gov/pubmed/28344887 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1273309 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|